DGCI nod to Covaxin for use in children above 12 years with certain conditions

The Drugs Controller General of India (DCGI) has granted emergency use authorisation to Bharat Biotech's Covaxin for children above 12 years with certain conditions, sources said on Saturday.

migrator

Published:25th Dec, 2021 at 9:47 PM

Chennai

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

"The recommendations of the SEC were evaluated by another experts committee after which DCGI had sought additional data from the firm," a source said.

The DCGI gave its approval Friday, the source said.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

DGCI nod to Covaxin for use in children above 12 years with certain conditions

The Drugs Controller General of India (DCGI) has granted emergency use authorisation to Bharat Biotech's Covaxin for children above 12 years with certain conditions, sources said on Saturday.

Also Read

Initial probe suggests cough syrup scam has Samajwadi Party links: Adityanath

IIT-M, Google launch AI capacity-building programme for govt officials

BJP defends VB- G RAM G overhaul, says new Bill aims at Viksit Bharat

Demand for old pension scheme: GoM to hold crucial meet on Monday

No more Pit Bulls, Rottweilers in Chennai from Dec 20